Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05352750 · ClinicalTrials.gov registry record · Phase 1

Phase 1 Study of SON-1010 in Adult Patients With Advanced Solid Tumors

A Phase 1 study of Advanced Solid Tumor and Soft Tissue Sarcoma Adult, sponsored by Sonnet BioTherapeutics.

Active
Registry status
Phase 1
Development phase
42
Enrollment target
1
Study location

NCT05352750 is a Phase 1 study of Advanced Solid Tumor and Soft Tissue Sarcoma Adult that is active but no longer recruiting, run by Sonnet BioTherapeutics. The registered enrollment target is 42 participants, below the 193-participant average among 189 other Advanced Solid Tumor trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05352750, a Phase 1 study of Advanced Solid Tumor and Soft Tissue Sarcoma Adult, is active but no longer recruiting, sponsored by Sonnet BioTherapeutics.

ACTIVE NOT RECRUITING
Registry status
Phase 1
Development phase
42 participants
Enrollment target
1
Study location

Study Summary

This is a Phase 1, first-in-human, open-label, adaptive-design outpatient study to assess the safety, tolerability, and PK/PD of SON-1010 administered to patients with advanced solid tumors.

Conditions Studied

Advanced Solid Tumor Soft Tissue Sarcoma Adult

Interventions

  • BIOLOGICAL SON-1010

Study Locations (1)

California

  • Sarcoma Oncology Center - Santa Monica

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2022-04-20
Est. Completion 2026-06-30
Phase Phase 1

Sponsor

Sonnet BioTherapeutics

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05352750

The ClinicalTrials.gov registry entry for NCT05352750 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 193-participant average among 189 other Advanced Solid Tumor trials with a reported enrollment target (78% lower). The listed sponsor is Sonnet BioTherapeutics, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Advanced Solid Tumor appearing as the primary indexed condition, and to 1 intervention - of which SON-1010 is the first listed.

NCT05352750 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT05352750 about?

NCT05352750 is a clinical study titled "Phase 1 Study of SON-1010 in Adult Patients With Advanced Solid Tumors". This is a Phase 1, first-in-human, open-label, adaptive-design outpatient study to assess the safety, tolerability, and PK/PD of SON-1010 administered to patients with advanced solid tumors.

What is the current status of trial NCT05352750?

This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 42 participants. The study started on 2022-04-20. Estimated completion is 2026-06-30.

What conditions does trial NCT05352750 study?

This clinical trial studies the following conditions: Advanced Solid Tumor, Soft Tissue Sarcoma Adult.

What interventions are being tested in trial NCT05352750?

The interventions under investigation include: SON-1010 (BIOLOGICAL).

Who is sponsoring clinical trial NCT05352750?

This trial is sponsored by Sonnet BioTherapeutics, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05352750 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Advanced Solid Tumor

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Advanced Solid Tumor

All registered trials for this condition

Soft Tissue Sarcoma Adult

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.